Predictors of neurocardiogenic injury after subarachnoid hemorrhage. 2004

Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
Division of Cardiology, UCSF Medical Center, USA.

OBJECTIVE Subarachnoid hemorrhage (SAH) frequently results in myocardial necrosis with release of cardiac enzymes. Historically, this necrosis has been attributed to coronary artery disease, coronary vasospasm, or oxygen supply-demand mismatch. Experimental evidence, however, indicates that excessive release of norepinephrine from the myocardial sympathetic nerves is the most likely cause. We hypothesized that myocardial necrosis after SAH is a neurally mediated process that is dependent on the severity of neurological injury. METHODS Consecutive patients admitted with SAH were enrolled prospectively. Predictor variables reflecting demographic (age, sex, body surface area), hemodynamic (heart rate, systolic blood pressure), treatment (phenylephrine dose), and neurological (Hunt-Hess score) factors were recorded. Serial cardiac troponin I measurements and echocardiography were performed on days 1, 3, and 6 after enrollment. Troponin level was treated as a dichotomous outcome variable. We performed univariate and multivariate analyses on the relationships between the predictor variables and troponin level. RESULTS The study included 223 patients with an average age of 54 years. Twenty percent of the subjects had troponin I levels >1.0 microg/L (range, 0.3 to 50 microg/L). By multivariate logistic regression, a Hunt-Hess score >2, female sex, larger body surface area and left ventricular mass, lower systolic blood pressure, and higher heart rate and phenylephrine dose were independent predictors of troponin elevation. CONCLUSIONS The degree of neurological injury as measured by the Hunt-Hess grade is a strong, independent predictor of myocardial necrosis after SAH. This finding supports the hypothesis that cardiac injury after SAH is a neurally mediated process.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography

Related Publications

Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
October 2008, The Journal of emergency medicine,
Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
February 2020, Neurocritical care,
Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
January 2010, Reviews in cardiovascular medicine,
Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
May 2006, Circulation,
Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
April 2014, Neurocritical care,
Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
January 2002, Stroke,
Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
January 2014, Cardiology journal,
Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
December 2023, Annals of clinical and translational neurology,
Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
March 2012, Neurology,
Poyee Tung, and Alexander Kopelnik, and Nader Banki, and Ken Ong, and Nerissa Ko, and Michael T Lawton, and Daryl Gress, and Barbara Drew, and Elyse Foster, and William Parmley, and Jonathan Zaroff
December 2013, Neurocritical care,
Copied contents to your clipboard!